RxDoctor Payments Data

Ahmed El-Eshmawi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1164723672

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,147 of the $2,486 with a category attached, or 86.4%. Abbott accounts for 65.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,131 and has fallen 83.3% since, to $189 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in NY, where the typical reported total is $3,409.

$2,486in general payments, 2019–2025

Across 29 payments — averaging $85.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$663
  • Atricure, Inc.$110
  • Edwards Lifesciences$89
$196,058in research payments, 2019–2025

Across 84 payments — averaging $2334.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$118K
  • Medtronic$48K
  • AbbVie$29K

What the payments were for

  • Travel & lodging$27911%
  • Food & beverage$2,14786%
  • Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott14$1,623
Medtronic10$663
Atricure, Inc.3$110
Edwards Lifesciences2$89

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,486 in reported general payments places this provider in the 40th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York

Medicare billing

Part B allowed, 2024
$226,397
Medicare patients
110
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →